Quddusi, Shaista <br/><br/>
Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans.  [electronic resource] 

 -  Diabetes care  Mar 2003 
 - 791-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0149-5992 
<br/><br/><label>Standard No.: </label>10.2337/diacare.26.3.791  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Blood Glucose--drug effects<br/>Diabetes Mellitus, Type 2--drug therapy<br/>Female<br/>Glucagon--administration & dosage<br/>Glucagon-Like Peptide 1<br/>Humans<br/>Infusions, Intravenous<br/>Insulin--metabolism<br/>Insulin Secretion<br/>Islets of Langerhans--drug effects<br/>Male<br/>Middle Aged<br/>Peptide Fragments--administration & dosage<br/>Protein Precursors--administration & dosage